References
- Eskola J, Anttila M. Pneumococcal conjugate vaccines. Pediatr Infect Dis J 1999; 18 : 543–51.
- Butler JC, Shapiro ED, Carlone GM. Pneumococcal vaccines: history, current status, and future directions. Am J Med 1999; 107: 69S–76S.
- Gwaltney JMJr, Scheld WM, Sande MA, Sydnor A. The microbial etiology and antimicrobial therapy of adults with acute community-acquired sinusitis: a fifteen-year experience at the University of Virginia and review of other selected studies. J Allergy Clin Immunol 1992; 90: 457–61.
- Tahkokallio O, Seppälä IJT, Sarvas H, Käyhty H, Mattila P. Concentrations of serum immunoglobulins and antibodies to pneumococcal capsular polysaccharides in patients with recurrent purulent sinusitis. Ann Otol Rhinol Laryngol 2000; in press.
- Sankilampi U, Herva E, Haikala R, Liimatainen O, Renkonen OV, Leinonen M. Epidemiology of invasive Streptococcus pneumoniae infections in adults in Finland. Epidemiol Infect 1997; 118: 7–15.
- Smart LE, Dougall AJ, Girdwood RW. New 23-valent pneumococcal vaccine in relation to pneumococcal serotypes in systemic and non-systemic disease. J Infect 1987; 14: 209–15.
- Butler JC, Breiman RF, Lipman HB, Hofmann J, Facklam RR. Serotype distribution of Streptococcus pneumoniae infections among preschool children in the United States, 19781994: implications for development of a conjugate vaccine. J Infect Dis 1995; 171: 885–9.
- Smith T, Lehmann D, Montgomery J, Gratten M, Riley ID, Alpers MP. Acquisition and invasiveness of different serotypes of Streptococcus pneumoniae in young children. Epidemiol Infect 1993; 111: 27–39.
- Hansman D. Serotypes in pneumococcal disease. A ten year study in Australia 1970 through 1979. Aust NZ J Med 1983; 13: 359–64